Effects of decarboxylase inhibitors on muricidal suppression by L-dopa in thiamine deficient rats

Archives Internationales De Pharmacodynamie Et De Therapie
|February 1, 1987
PubMed

Insights

Thiamine deficiency in rats induced mouse-killing behavior (muricide). Administration of l-dopa suppressed muricide, suggesting a role for brain catecholamines in this behavior.

Area of Science:

  • Neuroscience
  • Behavioral Pharmacology
  • Nutritional Neuroscience

Background:

  • Thiamine deficiency is linked to behavioral changes, including aggression.
  • Mouse-killing behavior (muricide) can be induced by specific dietary deficiencies.

Purpose of the Study:

  • To investigate the role of catecholamines in thiamine deficiency-induced muricide.
  • To characterize the pharmacological mechanisms underlying muricide suppression by l-dopa.

Main Methods:

  • Male Wistar rats were fed a thiamine-deficient diet to induce muricide.
  • Intraperitoneal injections of l-dopa and related compounds were administered.
  • The effects of catecholamine depletors and precursors on muricide incidence were assessed.

Main Results:

  • Thiamine deficiency induced muricide in 70% of rats by day 30.
  • L-dopa dose-dependently suppressed muricide, an effect potentiated by carbidopa.
  • The suppressive effect of l-dopa was reduced by agents inhibiting its conversion to noradrenaline.
  • Other noradrenaline precursors and catecholamine-enhancing agents also suppressed muricide.
  • Catecholamine depletors did not significantly alter muricide incidence.

Conclusions:

  • L-dopa's suppression of muricide is dependent on its decarboxylation and conversion to noradrenaline in the brain.
  • While brain catecholamines may not directly mediate thiamine deficiency-induced muricide, the behavior can be pharmacologically modulated by catecholaminergic agents.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...